Qilian IPO: 10 Things for Potential QLI Stock Investors to Know About the Chinese Pharma – InvestorPlace

0
35

Qilian (NASDAQ:QLI) is catching the eyes of investors on Tuesday as shares of its stock started trading today.

A scientist holds a test tube while it is in a container

Source: Shutterstock

Qilian shares are trading today after the company revealed its IPO price of $5 per share on Monday. It’s listing 5 million shares of its stock and expects the IPO to generate $25 million. The offering also includes an option for underwriters to purchase an additional 750,000 shares.

Here’s everything potential investors need to know about Qilian with its IPO underway.

  • Qilian is a pharmaceutical company based out of Gansu, China.
  • The company’s stock is listed on the Nasdaq Exchange under the QLI stock ticker.
  • The company’s focus is on the development, manufacturing, and marketing of certain products in the country.
  • That includes “licorice products, oxytetracycline products, traditional Chinese medicine derivatives product, heparin product, sausage casings, and fertilizers.”
  • It currently sells these goods in more than 20 provinces in China.
  • Qilian is still a fairly new company having only been founded in February 2019.
  • The company is led by chairman and CEO Zhanchang Xin.
  • Xin brings with him more than 30 years of experience in research and engineering in the pharmaceutical industry.
  • While it’s only the first day of trading for QLI stock, investors are still quickly snatching up shares.
  • As of this writing, more than 5 million shares of the stock have changed hands.

QLI stock was up 150% as of Tuesday afternoon.

On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article.

LEAVE A REPLY

Please enter your comment!
Please enter your name here